Interpretation of FibroTest Results with Elevated Alpha-2-Macroglobulin

Understanding the FibroTest Results

A FibroTest score of 0.21 indicates no liver fibrosis (F0) according to the Metavir scale, as recommended by the American Association for the Study of Liver Diseases 1
An ActiTest score of 0.04 indicates no inflammatory activity (A0) according to the Metavir scale, as recommended by the American Association for the Study of Liver Diseases 1
Elevated alpha-2-macroglobulin levels should be interpreted in the context of the overall FibroTest results, with mildly elevated levels being less concerning when the overall score is within the normal range, as noted by the European Association for the Study of the Liver 2, 3

Alpha-2-macroglobulin is one of the five biochemical markers used in FibroTest, and its elevation can be due to various non-hepatic causes, including inflammatory conditions, as stated by the European Association for the Study of the Liver 2, 4
Isolated elevation of alpha-2-macroglobulin without corresponding elevation in the overall FibroTest score suggests that this is likely not clinically significant for liver fibrosis, according to the American Association for the Study of Liver Diseases 3

No specific treatment is required for liver fibrosis when the FibroTest indicates no fibrosis (F0), as recommended by the American Association for the Study of Liver Diseases 1, 5
Documenting baseline values for future comparison is essential for monitoring liver health, as suggested by the American College of Gastroenterology 6
Repeat FibroTest in 12 months to monitor for any progression, as recommended by the American Association for the Study of Liver Diseases 1, 7
Consider standard liver function tests (ALT, AST, bilirubin, albumin) at 6-month intervals, as suggested by the American College of Gastroenterology 6

Addressing risk factors for liver disease (alcohol use, viral hepatitis, metabolic syndrome) is crucial, regardless of the current normal fibrosis score, as recommended by the American Association for the Study of Liver Diseases 5, 8
Continuing routine monitoring is necessary if the patient is on medications with potential hepatotoxicity, as stated by the American Academy of Dermatology 9

The reliability of FibroTest results depends on compliance with preanalytical and analytical conditions, as noted by the European Association for the Study of the Liver 2
Isolated extreme values of one component (like alpha-2-macroglobulin) should lead to caution in interpreting results, but when the overall score is within the normal range, this is less concerning, as stated by the European Association for the Study of the Liver 2
The test may not be reliable in cases of acute hemolysis, acute hepatitis, acute inflammation, or extrahepatic cholestasis, as noted by the European Association for the Study of the Liver 2

If clinical symptoms of liver disease develop, further evaluation is necessary, as suggested by the American College of Gastroenterology 6
If other liver function tests become abnormal, further evaluation is necessary, as suggested by the American College of Gastroenterology 6
If future FibroTest scores show progression (increase above 0.21), further evaluation is necessary, as recommended by the American Association for the Study of Liver Diseases 1, 7
If the patient has risk factors for liver disease progression that warrant closer monitoring, further evaluation is necessary, as recommended by the American Association for the Study of Liver Diseases 5, 8